XML 49 R35.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Tables)
 9 Months Ended
Sep. 30, 2024
Stockholders' Equity Note [Abstract]  
Schedule of Stock Options Activity
A summary of the stock option activity under the Company’s equity incentive plans is presented below:
Number of
Shares		Weighted
Average
Exercise
Price		Weighted
Average
Remaining
Term		Aggregate
Intrinsic
Value
Balance as of December 31, 2023845$24.98 1.71$— 
Granted7,213 2.18 — — 
Exercised— 3.00 — — 
Forfeited(159)4.71 — — 
Expired(611)23.98 — — 
Balance as of September 30, 20247,288$2.94 9.49$3,438 
Expected to vest at September 30, 20247,288$2.94 9.49$3,438 
Exercisable at September 30, 2024178$31.54 4.47$1 
Schedule of Restricted Stock Unit (“RSU”) Activity
A summary of restricted stock unit (“RSU”) activity is presented below:
SharesWeighted Average Grant-
Date Fair Value
Outstanding as of December 31, 20232,190$3.74 
Granted928 1.38 
Vested(1,135)3.79 
Forfeited(485)3.73 
Outstanding as of September 30, 20241,498$2.25 
Schedule of Stock-Based Compensation Expense
The following table summarizes stock-based compensation expense included in the condensed consolidated statements of operations:
Three Months Ended September 30,Nine Months Ended September 30,
2024202320242023
Cost of revenue, excluding depreciation and amortization$430 $220 $1,006 $744 
Sales and marketing203 236 404 681 
General and administrative971 1,184 2,518 3,320 
Research and development1
135 67 310 (221)
Total$1,739 $1,707 $4,238 $4,524 
________________________________
(1) The negative stock-based compensation expense for the nine months ended September 30, 2023 for research and development was due to forfeitures.